Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

82
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
82
Modified-Release Drug Delivery Systems: Rate-Programmed II01:19

Modified-Release Drug Delivery Systems: Rate-Programmed II

72
Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...
72
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention01:05

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

297
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
297
Modified-Release Drug Delivery Systems: Classification01:23

Modified-Release Drug Delivery Systems: Classification

192
Modified-release drug delivery systems improve drug efficacy and minimize side effects by controlling the rate and location of drug release. These systems fall into three categories: rate-programmed, stimuli-activated, and site-targeted.Rate-programmed systems release drugs at a predetermined rate, maintaining consistent therapeutic levels and reducing fluctuations that could lead to toxicity or subtherapeutic effects. These systems use polymeric matrices, reservoir-based designs, or osmotic...
192
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

73
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
73
Modified-Release Drug Delivery Systems: Stimuli-Activated01:30

Modified-Release Drug Delivery Systems: Stimuli-Activated

74
Stimuli-activated drug delivery systems are designed to release drugs in response to specific physical, chemical, or biological stimuli. These systems often utilize hydrogels—three-dimensional, hydrophilic polymer networks capable of swelling in aqueous environments and retaining significant fluid volumes. Upon exposure to particular stimuli, these hydrogels undergo structural transitions that allow the embedded drug to be released. Due to this adaptive behavior, such systems are also...
74

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Best Practices in Physiologically Based Pharmacokinetic (PBPK) Modeling.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Unravelling the Intrinsic Reactivity and Colloidal Instability in Tin-Based Halide Perovskite Precursor Solutions.

Angewandte Chemie (International ed. in English)·2026
Same author

Open Systems Pharmacology Community Conference (OSP-CC) Proceedings 2025.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Advancing Quantitative <sup>31</sup>P NMR Spectroscopy for Reliable Thiol Group Analysis.

ACS macro letters·2026
Same author

Nanosized Li<sub>2</sub>S-Loaded Polar Porous Carbon Nanofibers as Self-Supporting Electrodes in Anode-Free Lithium-Sulfur Batteries.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025
Same author

Small-Angle X-ray Scattering Monitoring of Porosity Evolution in Iron-Nitrogen-Carbon Electrocatalysts.

ACS nano·2025

関連する実験動画

Updated: Mar 18, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

9.1K

薬剤製剤添加物を,放出媒介ペプチド中間層による精密添加物へと進める

Sebastian Wieczorek, André Dallmann, Zdravko Kochovski1

  • 1Soft Matter and Functional Materials, Helmholtz-Zentrum Berlin für Materialien und Energie , Hahn-Meitner-Platz 1, Berlin, Germany.

Journal of the American Chemical Society
|July 12, 2016
PubMed
まとめ
この要約は機械生成です。

パルミチン酸ポリエチレングリコール (Pal-PEG) と特定のペプチドを用いた新薬配合添加物は,薬物の放出を正確に制御する. この技術革新により 薬剤の溶解性と投与運動性が向上し 治療の応用が進んでいます

さらに関連する動画

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.9K
Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.8K

関連する実験動画

Last Updated: Mar 18, 2026

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications
09:39

Injectable Supramolecular Polymer-Nanoparticle Hydrogels for Cell and Drug Delivery Applications

Published on: February 7, 2021

9.1K
A Tripeptide-Stabilized Nanoemulsion of Oleic Acid
10:42

A Tripeptide-Stabilized Nanoemulsion of Oleic Acid

Published on: February 27, 2019

9.9K
Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid
05:08

Solubility of Hydrophobic Compounds in Aqueous Solution Using Combinations of Self-assembling Peptide and Amino Acid

Published on: September 20, 2017

17.8K

科学分野:

  • 薬物投与システム
  • ポリマー化学
  • バイオコンジュガート化学

背景:

  • 効果的な薬物投与システムを開発することは 治療の成功に不可欠です
  • 現在の製剤は,薬の溶解性,安定性,および制御された放出に関する課題に直面することが多い.
  • ポリエチレングリコール (PEG) は溶解性および生物適合性のために広く使用され,水性成分は薬物の負荷を助けることができます.

研究 の 目的:

  • 薬剤の放出プロファイルを正確に制御するための新しいアンフィフィリック製剤添加物を開発する.
  • 薬剤の溶解性を高め,高い薬剤負荷能力を達成するシステムを構築する.
  • 薬剤活性化運動を調節する際の特製ペプチドの役割を調査する.

主な方法:

  • パルミチン酸改性ポリエチレングリコール (Pal-PEG) を基に合成されたアンフィフィリック添加物.
  • 薬剤結合ペプチドが含まれており,水嫌性-水好性インターフェイスで組み合わせ方法によって選択されています.
  • 開発された添加物を用いて光敏感剤を製定した.
  • 薬物の負荷,溶解性,および活性化調節を含む放出運動を評価した.

主要な成果:

  • Pal-PEG添加物は1:1の比率に近い高い薬効負荷を達成しました.
  • この配列は,光敏感剤を水溶性にするのに成功しました.
  • ペプチドインターフェース層の微調整により,薬剤活性化運動が調整できる.
  • このペプチドは,薬剤の放出プロフィールの正確な調節を可能にしました.

結論:

  • パル-PEGベースの添加物は,高度な薬物製剤のための多用途のプラットフォームを提供します.
  • このアプローチにより,溶解性が向上し,高い薬物負荷,調整可能な放出/活性化運動性が得られます.
  • このシステムは,光敏感剤を含む様々な治療薬の効能と投与の改善を約束しています.